From ocular oncology to tackling neglected diseases, our 2020 Power Listers are making their mark on ophthalmology – and beyond.
Advances in genotyping offer great potential in the prediction of ocular disease and treatment outcomes – but also present ethical challenges
How a cross-sectional study raised the glaucoma referral threshold by 3 mmHg – and reduced referrals by 67 percent
New data show that selective laser trabeculoplasty is a safe first-line option for glaucoma and ocular hypertension
The challenges of delivering high-quality eye care to an aging population
Sitting Down With… Sir Peng Tee Khaw, Consultant Ophthalmic Surgeon at Moorfields Eye Hospital
Can a glaucoma diagnosis do more harm than good? Let's see what the experts have to say...
The perils of diagnosing patients as "glaucoma suspects"
How second-generation devices ease concerns and simplify adoption
The IGA's advice on continued eye drop use and punctual occlusion for patients observing Ramadan
MIGS has not superseded trabeculectomy, argues Philip Bloom
Send me the latest from The Ophthalmologist.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.